Skip to main content
Clinical Trials/NCT06354621
NCT06354621CompletedPhase 1

Impact of Vitamin D Supplementation on Fetomaternal Outcomes in Pregnant Females With Latent Tuberculosis Infection: A Randomized Controlled Trial in Lahore-Punjab

University of the Punjab1 site in 1 country99 target enrollmentStarted: September 1, 2023Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Phase 1
Status
Completed
Enrollment
99
Locations
1
Primary Endpoint
Gestational Diabetes Mellitus (Maternal Outcome)

Study Overview

Brief Summary

The goal of this randomized controlled trial is to see the effect of vitamin D supplementation on fetomaternal outcomes in pregnant females with Latent Tuberculosis infection

The main question[s] it aims to answer are:

If Vitamin D supplementation has any impact on maternal outcomes. If Vitamin D supplementation has any impact on fetal outcomes.

Detailed Description

This study aims to see the impact of vitamin D supplementation on fetomaternal outcomes in pregnant females with latent tuberculosis infection. A three-arm (parallel) randomized controlled trial (RCT) will be conducted in a high-burden setting. A calculated sample of 99 (33 in each group) pregnant females with LTBI will be enrolled based on predefined inclusion criteria. Vitamin D supplementation will be given as per study protocols. Group-A (No intervention), Group-B (2000IU/day), Group-C (4000IU/day). To maintain the safety measures throughout the study all the study participants will be monitored for hypervitaminosis D. Informed consent will be obtained from all participants. The study will be conducted after approval by the ethical review board(s). The final analysis will be based on the effect of vitamin D supplementation on pre-defined fetomaternal outcomes.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Supportive Care
Masking
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to 35 Years (Adult)
Sex
Female
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •- Pregnant females aged 18-35 years, already enrolled for delivery in the specified setting coming regularly for prenatal checkups with positive tuberculin skin test

Exclusion Criteria

  • •History of active T.B
  • •Use of any dietary supplement containing more than 400 IU/day (10 mcg/day) of vitamin D within the month before enrolment;
  • •Presence of any confounders;

Arms & Interventions

Group-A (Control Group)

No Intervention

Participants receiving standard antenatal care without having any vitamin-D supplementation/intervention

Group-C (4000IU/day)

Experimental

Participants receiving 4000IU/day of Vitamin-D supplementation, in addition to having standard antenatal care

Intervention: Vitamin-D supplementation (Dietary Supplement)

Group-B (2000IU/day)

Experimental

Participants receiving 2000IU/day of Vitamin-D supplementation, in addition to having standard antenatal care

Intervention: Vitamin-D supplementation (Dietary Supplement)

Outcomes

Primary Outcomes

Gestational Diabetes Mellitus (Maternal Outcome)

Time Frame: Three months

Incidence of Gestational diabetes (percentage of females having abnormal glucose intolerance i.e. fasting glucose \> 92mg/dL, after using 75g glucose load one-hour glucose \> 180mg/dL or two-hour glucose \> 153mg/dL)

Pre-Eclampsia (Maternal Outcome)

Time Frame: Three months

Incidence of Pre-eclampsia (percentage of Females having proteinuria on urine dip test with blood pressure \> 140/90 mmHg)

Pre-Term delivery (Foetal Outcome)

Time Frame: One month

Incidence of pre-term delivery (percentage of live births before 37 completed gestation weeks)

Low Birth Weight (Foetal Outcome)

Time Frame: One month

Incidence of low birth weight babies (percentage of neonates weighing \<2.5kg)

C/Section delivery (Maternal Outcomes)

Time Frame: Three months

Incidence of Caesarean delivery (% age of females having surgical delivery of baby via incision on abdomen and uterus)

Apgar Score (Foetal Outcome)

Time Frame: One month

Apgar scores (The 10-point Apgar score has been used to assess the condition and prognosis of newborn infants throughout the world. Each of five easily identifiable characteristics i.e. heart rate, respiratory effort, muscle tone, reflex irritability, and color is assessed and assigned a value of 0 to 2. The total score is the sum of the five components, and a score of 7 or higher indicates that the baby's condition is good to excellent. The Apgar score is determined at one and five minutes after delivery and is therefore a rapid way to evaluate the physical condition of newborn infants. Of the two scores, the five-minute score has come to be regarded as the better predictor of survival in infancy.)

Secondary Outcomes

  • Improvement in maternal vitamin-D levels(Two-Three months)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

USMAN JAVED IQBAL

Principal Investigator

University of the Punjab

Study Sites (1)

Loading locations...

Similar Trials